{"id":39602,"date":"2026-08-20T10:15:56","date_gmt":"2026-08-20T08:15:56","guid":{"rendered":"https:\/\/ggba.swiss\/?p=39602"},"modified":"2026-08-20T10:15:58","modified_gmt":"2026-08-20T08:15:58","slug":"spineart-receives-fda-approval-for-its-baguera-c-cervical-disc","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/","title":{"rendered":"Spineart receives FDA approval for its BAGUERA C cervical disc"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.spineart.com\/\">Spineart<\/a>, a medtech company based in Plan-les-Ouates in the canton of Geneva, has announced that its BAGUERA C cervical disc has received approval from the US Food and Drug Administration for one and two contiguous levels. The approval expands access in the United States to a motion-preserving solution for patients with cervical disc disease, in a market with relatively few cervical disc replacement options.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">One of the company&#8217;s foundational technologies and a cornerstone of its cervical portfolio, BAGUERA C brings nearly two decades of international clinical experience, with more than 80,000 devices sold worldwide since its introduction. The FDA approval is supported by two randomized controlled trials enrolling nearly 600 patients in the United States. Additional clinical evidence includes a ten-year follow-up study published in The European Spine Journal in 2023, which found that 85 percent of implants maintained motion a decade after treatment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The device offers surgeons an alternative to spinal fusion in appropriately selected patients, preserving motion at the treated level rather than immobilizing it. Its addition to the company&#8217;s US offering strengthens a portfolio of spine technologies spanning motion preservation, posterior fixation, interbody fusion, enabling technologies and biologics.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Spineart received the Prix de l&#8217;\u00c9conomie Genevoise in 2022 for its contribution to technological and scientific innovation, commercial activity, job creation and ESG principles.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Spineart, the Geneva-based medtech company specializing in spine surgery, has received FDA approval for its BAGUERA C cervical disc for one and two contiguous levels, expanding access in the United States to a motion-preserving solution for cervical disc disease.<\/p>\n","protected":false},"author":6,"featured_media":39603,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[890,963,926,886],"class_list":["post-39602","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-healthcare","tag-medical-devices","tag-medtech","tag-rd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Spineart receives FDA approval for its BAGUERA C cervical disc<\/title>\n<meta name=\"description\" content=\"Spineart has received FDA approval for its BAGUERA C cervical disc, expanding US access to a motion-preserving alternative to spinal fusion.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spineart receives FDA approval for its BAGUERA C cervical disc\" \/>\n<meta property=\"og:description\" content=\"Spineart has received FDA approval for its BAGUERA C cervical disc, expanding US access to a motion-preserving alternative to spinal fusion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-20T08:15:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-20T08:15:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/Spinart-Baguerra-C-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Spineart receives FDA approval for its BAGUERA C cervical disc\",\"datePublished\":\"2026-08-20T08:15:56+00:00\",\"dateModified\":\"2026-08-20T08:15:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/\"},\"wordCount\":223,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/Spinart-Baguerra-C-1180x811-1.jpg\",\"keywords\":[\"Healthcare\",\"Medical Devices\",\"Medtech\",\"R&amp;D\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/\",\"url\":\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/\",\"name\":\"Spineart receives FDA approval for its BAGUERA C cervical disc\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/Spinart-Baguerra-C-1180x811-1.jpg\",\"datePublished\":\"2026-08-20T08:15:56+00:00\",\"dateModified\":\"2026-08-20T08:15:58+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Spineart has received FDA approval for its BAGUERA C cervical disc, expanding US access to a motion-preserving alternative to spinal fusion.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/Spinart-Baguerra-C-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/Spinart-Baguerra-C-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Spineart's BAGUERA C cervical disc has received FDA approval for one and two contiguous levels. | \u00a9 Spineart\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spineart receives FDA approval for its BAGUERA C cervical disc\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spineart receives FDA approval for its BAGUERA C cervical disc","description":"Spineart has received FDA approval for its BAGUERA C cervical disc, expanding US access to a motion-preserving alternative to spinal fusion.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/","og_locale":"en_US","og_type":"article","og_title":"Spineart receives FDA approval for its BAGUERA C cervical disc","og_description":"Spineart has received FDA approval for its BAGUERA C cervical disc, expanding US access to a motion-preserving alternative to spinal fusion.","og_url":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-08-20T08:15:56+00:00","article_modified_time":"2026-08-20T08:15:58+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/Spinart-Baguerra-C-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Spineart receives FDA approval for its BAGUERA C cervical disc","datePublished":"2026-08-20T08:15:56+00:00","dateModified":"2026-08-20T08:15:58+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/"},"wordCount":223,"image":{"@id":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/Spinart-Baguerra-C-1180x811-1.jpg","keywords":["Healthcare","Medical Devices","Medtech","R&amp;D"],"articleSection":["Life sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/","url":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/","name":"Spineart receives FDA approval for its BAGUERA C cervical disc","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/Spinart-Baguerra-C-1180x811-1.jpg","datePublished":"2026-08-20T08:15:56+00:00","dateModified":"2026-08-20T08:15:58+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Spineart has received FDA approval for its BAGUERA C cervical disc, expanding US access to a motion-preserving alternative to spinal fusion.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/Spinart-Baguerra-C-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/Spinart-Baguerra-C-1180x811-1.jpg","width":1180,"height":811,"caption":"Spineart's BAGUERA C cervical disc has received FDA approval for one and two contiguous levels. | \u00a9 Spineart"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/spineart-receives-fda-approval-for-its-baguera-c-cervical-disc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Spineart receives FDA approval for its BAGUERA C cervical disc"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/39602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=39602"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/39602\/revisions"}],"predecessor-version":[{"id":39606,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/39602\/revisions\/39606"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/39603"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=39602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=39602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=39602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}